Terry R. Barclay, PhD, LP
Research Investigator, Center for Memory & Aging, Regions Hospital
About

Joined the Institute: 2009

Education and training: PhD, clinical psychology, Michigan State University; residency in geropsychology, West Los Angeles VA Medical Center; fellowship in neuropsychology, David Geffen School of Medicine at the University of California, Los Angeles

Overview/research interests: Neuropsychology of normal aging, early detection of Alzheimer’s disease and related dementias and geriatric psychology.

Current research activities and funding:

  • Effects of physical activity, nutrition, and lifestyle factors on memory and other cognitive functions in community-dwelling older adults
  • The relationship between mental stimulation and brain health in aging populations
  • Novel treatments for cognitive impairment in Alzheimer’s disease and other dementias
Affiliation
positions
  • Research investigator, Center for Memory & Aging, Regions Hospital, Neuroscience Research Centers 2009 -
    • Publications While At HealthPartners
    selected publications
    Journal Article
  • A case of minimally progressive prodromal Alzheimer's disease. 
    Journal of Alzheimer's disease reports. 2023
  • Prodromal dementia with Lewy bodies: evolution of symptoms and predictors of dementia onset. 
    Journal of Geriatric Psychiatry and Neurology. 2022
  • A phase II, single-center, randomized, double-blind, placebo-controlled study of the safety and therapeutic efficacy of intranasal glulisine in amnestic mild cognitive impairment and probable mild Alzheimer's disease. 
    Drugs and Aging. 2021
  • Cognitive effects of aerobic exercise in Alzheimer's disease: a pilot randomized controlled trial. 
    Journal of Alzheimer's Disease. 2021
  • Double-blind placebo-controlled pilot investigation of the safety of a single dose of rapid-acting intranasal insulin in Down syndrome. 
    Drugs in R&D. 2020
  • Executive function: responses to aerobic exercise in Alzheimer's disease. 
    Geriatric Nursing (New York, N.Y.). 2018
  • Screening positive for cognitive impairment: impact on healthcare utilization and provider action in primary and specialty care practices. 
    Journal of General Internal Medicine. 2018
  • Routine cognitive screening in a neurology practice: effect on physician behavior. 
    Neurology. Clinical practice. 2016
  • A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein e4 carriers with mild-moderate Alzheimer's disease. 
    CNS drugs. 2014
  • Elements of attention in HIV-infected adults: evaluation of an existing model. 
    Journal of Clinical and Experimental Neuropsychology. 2008
  • Neurocognition in individuals co-infected with HIV and hepatitis C. 
    Journal of Addictive Diseases. 2008
    • Conference Poster
  • Outcomes of an embedded resource and education program for patients and families with memory loss [poster]
    2017
  • Performance on cognitive screening is associated with increased retrospective healthcare utilization [poster]
    2015
  • Routine cognitive screening in a neurology practice: impact on physician behavior [poster]
    2015
  • The Minnesota Memory Project: baseline data from a longitudinal observational study of aging [poster]
    2015
  • Failure on cognitive screening predicts increased healthcare utilization [poster]
    2014
  • Routine cognitive screening in a general neurology clinic: impact on physician behavior [poster]
    2014
  • Evidence-based provider tools for efficient identification and management of cognitive impairment [poster]
    2013
  • The effect of intranasal rapid acting insulin on ApoE4 carriers with mild-moderate Alzheimer's disease [poster]
    2013
  • Feasibility of the mini-cog as a standardized cognitive screen in HealthPartners patients aged 70 and older [poster]
    2012
  • Specific types of memory complaints may provide an early warning sign of cognitive impairment in community dwelling older adults [poster]
    2012
  • The 6th Vital Sign Project: does cognitive screening in the elderly population improve clinical care [poster]?
    2012
  • Changes in cognitive function and plasma biomarkers in a pilot trial of a multi-domain intervention to prevent cognitive decline [poster]
    2010
  • The Minnesota Memory Project [poster]
    2010
    • Review
  • Does cognitive training prevent cognitive decline: a systematic review [systematic review]. 
    Annals of Internal Medicine. 2018
  • Over-the-counter supplement interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review [systematic review]. 
    Annals of Internal Medicine. 2018
  • Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review [systematic review]. 
    Annals of Internal Medicine. 2018
  • Physical activity interventions in preventing cognitive decline and Alzheimer-type dementia: a systematic review [systematic review]. 
    Annals of Internal Medicine. 2018
  • Interventions to prevent age-related cognitive decline, mild cognitive impairment, and clinical Alzheimer's-type dementia [review]
    2017
    • Abstract
  • Cognitive screening results from the Medicare annual wellness visit in a primary care practice [abstract]. 
    Alzheimer's & dementia. 2017
  • Mindfulness for early Alzheimer's Disease: a pilot study [abstract]. 
    Alzheimer's & dementia. 2017
  • Minnesota memory project: use of the Alberta Smell Test in a longitudinal aging cohort [abstract]. 
    Alzheimer's & dementia. 2016
  • Outcomes from routine cognitive screening in a health care system [abstract]. 
    Alzheimer's & dementia. 2016
  • Outcomes of a dementia resource and education program imbedded in a health care system [abstract]. 
    Alzheimer's & dementia. 2016
    • presentations
    Contact
    full name
  • Terry R. Barclay, PhD, LP
    • located in facility
    Quick Info
     
    Collaboration
    More Info